Hadassah Medical Center in Jerusalem was the first Israeli hospital to offer NanoKnife. They introduced this minimally invasive technology in 2018 for localized prostate cancer. The procedure uses electrical pulses to destroy cancer cells without harming critical surrounding tissues or nerves.
- Target conditions: Initially used for focal prostate cancer and now often treats pancreatic tumors.
- Tissue preservation: High-frequency pulses spare blood vessels and nerves during delicate surgical procedures.
- Recovery time: Most patients go home on the same day after the procedure.
- Specialized expertise: Surgeons like Dr. Almog Ben Yaacov at Sheba Medical Center undergo international NanoKnife training.
Bookimed Expert Insight: While Hadassah pioneered the technology, Sheba Medical Center has integrated NanoKnife into a multidisciplinary oncology framework. Dr. Almog Ben Yaacov at Sheba completed advanced NanoKnife training at King's College London. This international training helps specialists apply the technology to complex gastrointestinal and urological cases with high precision.
Patient Consensus: Patients note that the recovery is much faster compared to traditional thermal treatments. Many were relieved to find they could return to normal activities almost immediately. They often mention that the procedure felt less intensive and spared them from typical side effects.
